OBJECTIVE: To compare changes in regional bone mineral density (BMD) of the metacarpal joints measured by dual x ray absorptiometry (DXA) and digital x ray radiogrammetry (DXR) in relation to disease activity and radiographic outcome in a two year follow up study of patients with early RA and unclassified polyarthritis. PATIENTS AND METHODS: 72 patients with symmetrically swollen and tender second and third metacarpophalangeal or proximal interphalangeal joints for at least four weeks and less than two years were included. 51 patients fulfilled the ACR criteria for RA. 21 patients had unclassified polyarthritis. The patients with RA were divided into groups according to mean disease activity, average glucocorticoid dose, and MRI and x ray detected bone erosions in the hands. Clinical and biochemical measurements were made every month and an x ray examination of the hands and BMD of the metacarpal joints every six months. RESULTS: DXR BMD decreased significantly only in patients with RA from month 6 and was associated with the mean disease activity. Patients with RA and erosive as well as non-erosive disease showed a significant decrease in the rate of bone loss, greatest in those with erosive disease. No changes in BMD measured by DXA were seen in any patient group. CONCLUSION: DXR is a useful measure of the destructive disease activity in patients with RA and unclassified polyarthritis, providing valuable information about bone changes associated with disease activity and erosive disease in early RA. DXR is better than DXA for detecting and monitoring periarticular osteoporosis of the metacarpal bone.
OBJECTIVE: To compare changes in regional bone mineral density (BMD) of the metacarpal joints measured by dual x ray absorptiometry (DXA) and digital x ray radiogrammetry (DXR) in relation to disease activity and radiographic outcome in a two year follow up study of patients with early RA and unclassified polyarthritis. PATIENTS AND METHODS: 72 patients with symmetrically swollen and tender second and third metacarpophalangeal or proximal interphalangeal joints for at least four weeks and less than two years were included. 51 patients fulfilled the ACR criteria for RA. 21 patients had unclassified polyarthritis. The patients with RA were divided into groups according to mean disease activity, average glucocorticoid dose, and MRI and x ray detected bone erosions in the hands. Clinical and biochemical measurements were made every month and an x ray examination of the hands and BMD of the metacarpal joints every six months. RESULTS: DXR BMD decreased significantly only in patients with RA from month 6 and was associated with the mean disease activity. Patients with RA and erosive as well as non-erosive disease showed a significant decrease in the rate of bone loss, greatest in those with erosive disease. No changes in BMD measured by DXA were seen in any patient group. CONCLUSION: DXR is a useful measure of the destructive disease activity in patients with RA and unclassified polyarthritis, providing valuable information about bone changes associated with disease activity and erosive disease in early RA. DXR is better than DXA for detecting and monitoring periarticular osteoporosis of the metacarpal bone.
Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra Journal: Arthritis Rheum Date: 1988-03
Authors: D M Black; L Palermo; T Sørensen; J T Jørgensen; C Lewis; F Tylavsky; R Wallace; E Harris; S R Cummings Journal: J Clin Densitom Date: 2001 Impact factor: 2.963
Authors: Joachim Böttcher; Alexander Pfeil; Anders Rosholm; Max-Ludwig Schäfer; Ansgar Malich; Alexander Petrovitch; Bettina Seidl; Gabriele Lehmann; Hans-Joachim Mentzel; Gert Hein; Gunter Wolf; Werner A Kaiser Journal: J Digit Imaging Date: 2006-09 Impact factor: 4.056
Authors: L M Ørnbjerg; M Østergaard; T Jensen; K Hørslev-Petersen; K Stengaard-Pedersen; P Junker; T Ellingsen; P Ahlquist; H Lindegaard; A Linauskas; A Schlemmer; M Y Dam; I Hansen; T Lottenburger; C G Ammitzbøll; A Jørgensen; S B Krintel; J Raun; M L Hetland; Ole Slot; Lars Kjær Nielsen; Henrik Skjødt; Ole Majgaard; Tove Lorenzen; Hans Christian Horn; Marcin Kowalski; Inger Lauge Johansen; Peter Mosborg Pedersen; Natalia Manilo; Henning Bliddal Journal: Clin Rheumatol Date: 2016-12-05 Impact factor: 2.980
Authors: Melek Güler-Yüksel; Naomi B Klarenbeek; Yvonne P M Goekoop-Ruiterman; Jeska K de Vries-Bouwstra; Sjoerd M van der Kooij; Andreas H Gerards; H Karel Ronday; Tom W J Huizinga; Ben A C Dijkmans; Cornelia F Allaart; Willem F Lems Journal: Arthritis Res Ther Date: 2010-05-20 Impact factor: 5.156
Authors: Stephen R Pye; Judith E Adams; Kate A Ward; Diane K Bunn; Deborah P M Symmons; Terence W O'Neill Journal: Rheumatology (Oxford) Date: 2010-06-23 Impact factor: 7.580
Authors: Pernille Bøyesen; Mari Hoff; Sigrid Odegård; Glenn Haugeberg; Silje W Syversen; Per I Gaarder; Cecilie Okkenhaug; Tore K Kvien Journal: Arthritis Res Ther Date: 2009-07-01 Impact factor: 5.156